Snippet from the article:
Escalated-dose radiation therapy for localized prostate cancer did not significantly affect the frequency of biochemical or clinical failure compared with a standard protocol, a randomized trial showed.
Men treated by the standard radiotherapy protocol had a 5-year rate of combined biochemical and clinical failure of 21.43%, whereas the escalated-dose, or hypofractionated, protocol was associated with failure rate of 23.3%.
The incidence of late toxicity did not differ between protocols, but hypofractionated therapy worsened urinary function in men who had urinary problems at baseline, Alan Pollack, MD, PhD, of the University of Miami, and co-authors reported online in the Journal of Clinical Oncology.
Read the rest — Higher Radiation Dose No Help in Prostate Cancer